Pilot Study of Maintenance Therapy With Intravenous AMANTADINE

NCT01190553 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Amantadine

Sponsor

Rabin Medical Center